Design, Synthesis and Evaluation of a Series of Zinc(II) Complexes of Anthracene-Affixed Multifunctional Organic Assembly as Potential Antibacterial and Antibiofilm Agents against Methicillin-Resistant Staphylococcus aureus
Source abstract
Abstract
A novel class of zinc(II)-based metal complexes, i.e., [Zn 2 (acdp)(μ-Cl)]·2H 2 O ( 1 ), [Zn 2 (acdp)(μ-NO 3 )]·2H 2 O ( 2 ), and [Zn 2 (acdp)(μ-O 2 CCF 3 )]·2H 2 O ( 3 ) (Cl – = chloride; NO 3 – = nitrate; CF 3 CO 2 – = trifluoroacetate) of anthracene-affixed multifunctional organic assembly, H 3 acdp (H 3 acdp = N, N ′-bis[anthracene-2-ylmethyl]- N, N ′-bis[carboxymethyl]-1,3-diaminopropan-2-ol), have emerged as promising antibacterial and antibiofilm agents in the domain of medicinal chemistry. Accordingly, complexes 1 – 3 were synthesized by utilizing H 3 acdp in combination with ZnCl 2, Zn(NO 3 ) 2 ·6H 2 O, and Zn(CF 3 CO 2 ) 2 ·H 2 O respectively, in the presence of NaOH at ambient temperature. The complexation between H 3 acdp and Zn 2+ was delineated by a combined approach of spectrophotometric and spectrofluorometric titration studies. The stoichiometry of acdp 3– /Zn 2+ in all three complexes is observed to be 1:2, as confirmed by spectrophotometric/spectrofluorometric titration data. Elemental analysis (C, H, N, Zn), molar conductance, FTIR, UV–vis, and thermoanalytical (TGA/DTA) data were effectively used to characterize these complexes. Besides, the structures of 1 – 3 were established by density functional theory (DFT) calculation using B3LYP/6-311G, specifying a self-assembled compact geometry with average Zn···Zn separation of 3.4629 Å. All three zinc complexes exhibited significantly high antibacterial and antibiofilm activity against methicillin-resistant Staphylococcus aureus (MRSA BAA1717). However, complex 1 showed a more recognizable activity than 2 and 3, with minimum inhibitory concentration (MIC) values of 200, 350, and 450 μg/mL, respectively. The antimicrobial activity was tested by employing the minimum inhibitory concentration (MIC) and time-kill assay. The crystal violet (CV) assay and microscopic study were performed to examine the antibiofilm activity. As observed, complexes 1 – 3 had an effect on the production of extracellular polymeric substance (EPS), biofilm cell-viability, and other virulence factors such as staphyloxanthin and hemolysin production, autoaggregation ability, and microbial cell-surface hydrophobicity. Reactive oxygen species (ROS) generated due to inhibition of staphyloxanthin production in response to 1 – 3 were also analyzed. Moreover, complexes 1 – 3 showed an ability to damage the bacterial cell membrane due to accumulation of ROS resulting in DNA leakage. In addition, complexes 1 – 3 displayed a synergistic/additive activity with a commercially available antibiotic drug, vancomycin, with enhanced antibacterial activity. On the whole, our investigation disclosed that complex 1 could be a promising drug lead and attract much attention to medicinal chemists compared to 2 and 3 from therapeutic aspects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Metal complexes synthesis and properties · Crystal structures of chemical compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Kalyani, Kalyani, Nadia, West Bengal 741235, India
Department of Microbiology, University of Kalyani, Kalyani, Nadia, West Bengal 741235, India
Funding
University Grants Commission · Department of Biotechnology, Government of West Bengal · Department of Science and Technology, Ministry of Science and Technology, India · University of Kalyani · Department of Higher Education, Government of West Bengal
References (70)
Show source-provided references
1. 10.1021/acsinfecdis.9b0007810.1021/acsinfecdis.9b00078 ↗
2. 10.1038/nature1279010.1038/nature12790 ↗
3. 10.1021/acsfoodscitech.1c0005210.1021/acsfoodscitech.1c00052 ↗
4. 10.1021/acsami.0c0318710.1021/acsami.0c03187 ↗
5. 10.1021/acs.jafc.0c0633710.1021/acs.jafc.0c06337 ↗
6. 10.1016/j.biomaterials.2005.11.04410.1016/j.biomaterials.2005.11.044 ↗
7. 10.1042/bst031072310.1042/bst0310723 ↗
8. 10.1126/science.271.5252.108110.1126/science.271.5252.1081 ↗
9. 10.1039/b617121b10.1039/b617121b ↗
10. 10.1016/j.apsusc.2009.04.19810.1016/j.apsusc.2009.04.198 ↗
11. 10.1021/cr020626310.1021/cr0206263 ↗
12. 10.1016/j.str.2005.07.01410.1016/j.str.2005.07.014 ↗
13. 10.1046/j.0902-0055.2003.00109.x10.1046/j.0902-0055.2003.00109.x ↗
14. 10.4103/1305-7456.12626210.4103/1305-7456.126262 ↗
15. 10.1088/1748-6041/10/1/01500110.1088/1748-6041/10/1/015001 ↗
16. 10.1016/j.archoralbio.2017.09.02310.1016/j.archoralbio.2017.09.023 ↗
17. 10.1016/j.bbagen.2015.12.00610.1016/j.bbagen.2015.12.006 ↗
18. 10.1111/1346-8138.1276710.1111/1346-8138.12767 ↗
19. 10.1016/j.legalmed.2016.05.00210.1016/j.legalmed.2016.05.002 ↗
20. 10.1021/acs.inorgchem.2c0220110.1021/acs.inorgchem.2c02201 ↗
21. 10.1021/acs.biomac.9b0139110.1021/acs.biomac.9b01391 ↗
22. 10.1021/acsomega.0c0621810.1021/acsomega.0c06218 ↗
23. 10.1021/acs.inorgchem.8b0144110.1021/acs.inorgchem.8b01441 ↗
24. 10.1021/acs.inorgchem.1c0220110.1021/acs.inorgchem.1c02201 ↗
25. 10.1016/j.poly.2016.06.02810.1016/j.poly.2016.06.028 ↗
26. 10.1016/j.saa.2006.02.05010.1016/j.saa.2006.02.050 ↗
27. 10.1002/ejic.20050008410.1002/ejic.200500084 ↗
28. 10.1039/b900780f10.1039/b900780f ↗
29. 10.1016/j.molliq.2021.11548310.1016/j.molliq.2021.115483 ↗
30. 10.1021/ja01532a00910.1021/ja01532a009 ↗
31. 10.1021/ic300661c10.1021/ic300661c ↗
32. 10.1021/ja900980u10.1021/ja900980u ↗
33. 10.1002/slct.20210431910.1002/slct.202104319 ↗
34. 10.1021/ic100145e10.1021/ic100145e ↗
35. 10.1016/j.jaap.2017.10.00210.1016/j.jaap.2017.10.002 ↗
36. 10.1021/acs.inorgchem.6b0145510.1021/acs.inorgchem.6b01455 ↗
37. 10.1016/j.jaap.2018.03.01810.1016/j.jaap.2018.03.018 ↗
38. 10.1039/D1RA06902K10.1039/D1RA06902K ↗
39. 10.1039/C7NR08891D10.1039/C7NR08891D ↗
40. 10.1039/b108432c10.1039/b108432c ↗
41. 10.1016/j.poly.2019.03.01310.1016/j.poly.2019.03.013 ↗
42. 10.1039/C6DT02596J10.1039/C6DT02596J ↗
43. 10.1002/ejic.20060028810.1002/ejic.200600288 ↗
44. 10.1039/DT984000134910.1039/DT9840001349 ↗
45. Cockerill F. R. · 2015
46. 10.1021/am504779t10.1021/am504779t ↗
47. 10.1128/br.36.4.478-503.197210.1128/br.36.4.478-503.1972 ↗
48. 10.3389/fmicb.2020.62253410.3389/fmicb.2020.622534 ↗
49. 10.3389/fnagi.2014.0007710.3389/fnagi.2014.00077 ↗
50. 10.1016/j.micpath.2020.10412710.1016/j.micpath.2020.104127 ↗
51. 10.1016/j.micpath.2018.10.02910.1016/j.micpath.2018.10.029 ↗
52. 10.1021/ic202530j10.1021/ic202530j ↗
53. 10.1016/j.molstruc.2019.12688610.1016/j.molstruc.2019.126886 ↗
54. 10.1021/acsomega.1c0620510.1021/acsomega.1c06205 ↗
55. 10.3389/fmicb.2019.0245510.3389/fmicb.2019.02455 ↗
56. 10.1021/acsabm.0c0037210.1021/acsabm.0c00372 ↗
57. 10.1039/D1RA08555G10.1039/D1RA08555G ↗
58. 10.1039/D1NJ00468A10.1039/D1NJ00468A ↗
59. 10.1039/D1DT00657F10.1039/D1DT00657F ↗
60. 10.1039/C5RA08065G10.1039/C5RA08065G ↗
61. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Vreven, Jr., T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, Revision A.1; Gaussian, Inc.: Pittsburgh, PA, 2003.
62. 10.1063/1.46491310.1063/1.464913 ↗
63. 10.1063/1.167752710.1063/1.1677527 ↗
64. 10.1038/srep1926710.1038/srep19267 ↗
65. 10.3389/fmicb.2019.0202710.3389/fmicb.2019.02027 ↗
66. 10.1038/s41598-019-50207-y10.1038/s41598-019-50207-y ↗
67. 10.1016/j.micpath.2018.12.00710.1016/j.micpath.2018.12.007 ↗
68. 10.3389/fmicb.2020.0082310.3389/fmicb.2020.00823 ↗
69. 10.1016/j.ijbiomac.2012.06.00910.1016/j.ijbiomac.2012.06.009 ↗
70. 10.1016/j.porgcoat.2020.10605810.1016/j.porgcoat.2020.106058 ↗